CAS 1351758-37-6

RR6

CAS: 1351758-37-6

RR6

Reinheit: ≥98%

Molekulargewicht: 293.36g/mol

Ref: 54-BUP09119

RR6

CAS: 1351758-37-6

RR6

Reinheit: 98%

Molekulargewicht: 293.35812g/mol

Ref: 54-BICR380

RR6

CAS: 1351758-37-6

RR6 acts as a selective, reversible, and competitive vanin inhibitor at nanomolar concentration.

Formel: C₁₆H₂₃NO₄

Reinheit: 98.98%

Farbe und Form: Solid

Molekulargewicht: 293.36

Ref: TM-TQ0019

(2R)-2-hydroxy-3-(hydroxymethyl)-3-methyl-N-(3-oxo-4-phenylbutyl)butanamide

Kontrolliertes Produkt

CAS: 1351758-37-6

Formel: C₁₆H₂₃NO₄

Farbe und Form: Neat

Molekulargewicht: 293.36

Ref: TR-H942925

RR6

CAS: 1351758-37-6

RR6 is a glycol ether that is used in the treatment of metabolic disorders. It activates AMP-activated protein kinase (AMPK) and inhibits ATP citrate lyase, thereby increasing acetyl-CoA levels and decreasing fatty acid synthesis. RR6 also reduces oxidative stress by inhibiting the production of reactive oxygen species and inhibiting mitochondrial permeability transition pore opening. This drug has been shown to be effective against choroidal neovascularization, which may be due to its ability to reduce vascular endothelial growth factor levels. RR6 is a small molecule that can be administered orally or intravenously, making it an attractive candidate for drug development.

Formel: C₁₆H₁₈D₅NO₄

Reinheit: Min. 95%

Molekulargewicht: 298.39 g/mol

Ref: 3D-BEC75837